SmartPill Corporation

 Company Summary:
  • SmartPill Corporation develops and manufactures ingestible and capsule-based medical devices that aid in the diagnosis, definition, and therapeutic intervention of gastrointestinal disorders and diseases for veterinary and pharmaceutical markets.
Transaction Overview: Significance of the Transaction:
  • SmartPill technology strengthens Given Imaging’s value proposition to gastroenterologists by offering industry-leading patient-friendly GI diagnostics solutions.
  • The acquisition will ensure continued investment in clinical trials, market development and manufacturing efficiency to support future growth of SmartPill.
  • On 27 February, 2014, Covidien announced the its acquisition of Given Imaging. The acquisition is projected to add between $40 and $50 million per quarter in incremental revenue.
Healthios Role:
  • Healthios served as exclusive financial adviser to SmartPill Corporation.
  • This transaction demonstrates Healthios’ continued leadership as the "advisor of choice" to the most exciting emerging growth healthcare companies at the forefront of innovation.